CLINICAL_TRIALS
trial_result
· 2022-10-18
Clinical Trial Update: A Study of Abemaciclib in Participants With Cancer That is Advanced or Has Spread to Another Part(s) of the Body [Phase 1]
Summary
A Phase 1 study of abemaciclib in participants with advanced or metastatic cancer has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Neoplasm Metastasis | Phase 1 | Status: COMPLETED | Results posted: 2022-10-18